Adiponectin is an adipokine first described just over a decade ago. Produced almost
exclusively by adipocytes, adiponectin circulates in high concentrations in human plasma …

Metabolic syndrome (MetS) as a collection of obesity-associated disorders is associated
with inflammation, oxidative stress, pro-thrombotic state, elevated risk of developing …

Fenofibrate is a fibric acid derivative indicated for the treatment of severe
hypertriglyceridaemia and mixed dyslipidaemia in patients who have not responded to …

Diabetic kidney disease (DKD) is a major complication for diabetic patients. Adiponectin is
an insulin sensitizer and anti-inflammatory adipokine and is mainly secreted by adipocytes …

Objective Visfatin is a newly identified adipocytokine and recent studies indicated that
visfatin may have potential proinflammatory effect. However, its pathophysiological role in …

Adiponectin circulates in blood in multiple isoforms. High molecular weight (HMW)
adiponectin is thought to be most biologically active and promotes glucose uptake, insulin …

Visfatin is highly expressed in adipose tissue (mainly by the stromal cells), but it is also
ubiquitously present in most tissues. Visfatin, which plays a role in nicotinamide adenine …

Obesity and related metabolic syndromes have been recognized as important disease risks,
in which the role of adipokines cannot be ignored. Adiponectin (ADP) is one of the key …

Fenofibrate is a fibric acid derivative with lipid-modifying effects that are mediated by the
activation of peroxisome proliferator-activated receptor-α. Fenofibrate also has a number of …

Studies performed during the last decade indicate that adipose tissue is not only a site of
triglyceride storage but also an active endocrine organ which secretes many biologically …